Cassady Schiller Wealth Management’s Moderna MRNA Stock Holding History

Cassady Schiller Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$6.9K	Buy	166 +16	+11%	+$765	﹤0.01%	377
2024 Q3	$10K	Sell	150 -16	-10%	-$1.47K	﹤0.01%	317
2024 Q2	$19.7K	Hold	166	–	–	0.01%	273
2024 Q1	$17.7K	Buy	166 +2	+1%	+$202	0.01%	299
2023 Q4	$16.3K	Buy	164 +14	+9%	+$1.18K	0.01%	295
2023 Q3	$15.5K	Hold	150	–	–	0.01%	294
2023 Q2	$18.2K	Hold	150	–	–	0.01%	288
2023 Q1	$23K	Hold	150	–	–	0.01%	263
2022 Q4	$26.9K	Buy	+150	New	+$24.5K	0.02%	245
2022 Q1	–	Sell	-155	Closed	-$39K	–	409
2021 Q4	$39K	Buy	+155	New	+$45.3K	0.02%	223

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Cassady Schiller Wealth Management's MRNA Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Moderna (MRNA) stake by 11% in Q4 2024, buying an estimated $765 and bringing the position to 166 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Cassady Schiller Wealth Management first reported a position in MRNA in Q4 2021 and has held it in 10 quarters since. The position peaked at $39K in Q4 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

Cassady Schiller Wealth Management held 166 shares of Moderna worth $6.9K as of Q4 2024.
Cassady Schiller Wealth Management bought 16 Moderna shares in Q4 2024, an estimated $765.
Moderna made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #377 holding.
Cassady Schiller Wealth Management first reported a position in Moderna in Q4 2021 and has held it in 10 quarters since.
Cassady Schiller Wealth Management's Moderna position peaked at $39K in Q4 2021.
745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.